Chilblain-like Lesions after COVID-19 Vaccination: A Case Series
DOI:
https://doi.org/10.2340/actadv.v102.2076Keywords:
COVID-19, chilblains, vaccinesAbstract
Abstract is missing (Short communication)
Downloads
References
Kanitakis J, Lesort C, Danset M, Jullien D. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): histologic, immunofluorescence, and immunohistochemical study of 17 cases. J Am Acad Dermatol 2020; 83: 870-875.
https://doi.org/10.1016/j.jaad.2020.05.145 DOI: https://doi.org/10.1016/j.jaad.2020.05.145
Battesti G, Descamps V. Negative tests for SARS-CoV-2 infection do not rule out its responsibility for chilblains. Br J Dermatol 2020; 183: 1151.
https://doi.org/10.1111/bjd.19483 DOI: https://doi.org/10.1111/bjd.19483
Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, Chiaverini C, et al. Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic. JAMA Dermatol 2021; 157: 202-206.
https://doi.org/10.1001/jamadermatol.2020.4324 DOI: https://doi.org/10.1001/jamadermatol.2020.4324
Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 2020; 183: 729-737.
https://doi.org/10.1111/bjd.19327 DOI: https://doi.org/10.1111/bjd.19327
Lesort C, Kanitakis J, Donzier L, Jullien D. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that 'COVID toes' are due to the immune reaction to SARS-CoV-2. J Eur Acad Dermatol Venereol 2021; 35: e630-e632.
https://doi.org/10.1111/jdv.17451 DOI: https://doi.org/10.1111/jdv.17451
Davido B, Mascitti H, Fortier-Beaulieu M, Jaffal K, de Truchis P. 'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine. J Travel Med 2021; 28: taab024.
https://doi.org/10.1093/jtm/taab024 DOI: https://doi.org/10.1093/jtm/taab024
Meara AS, Silkowski M, Quin K, Jarjour W. A case of chilblains-like lesions post SARS-CoV-2 vaccine? J Rheumatol 2021; 48: 1754.
https://doi.org/10.3899/jrheum.210226 DOI: https://doi.org/10.3899/jrheum.210226
Holmes GA, Desai M, Limone B, Love, J, Tawfik M, Wong L, Furukawa B. A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology. JAAD Case Rep 2021; 16: 53-57.
https://doi.org/10.1016/j.jdcr.2021.07.038 DOI: https://doi.org/10.1016/j.jdcr.2021.07.038
Pileri A, Guglielmo A, Raone B, Patrizi A. Chilblain lesions after COVID-19 mRNA vaccine. Br J Dermatol 2021; 185: e3.
https://doi.org/10.1111/bjd.20060 DOI: https://doi.org/10.1111/bjd.20060
McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol 2021; 85: 46-55.
https://doi.org/10.1016/j.jaad.2021.03.092 DOI: https://doi.org/10.1016/j.jaad.2021.03.092
Cameli N, Silvestri M, Mariano M, Nisticò SP, Cristaudo A. Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol 2021; 35: e725-e727.
https://doi.org/10.1111/jdv.17500 DOI: https://doi.org/10.1111/jdv.17500
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Roberto Russo, Emanuele Cozzani, Claudia Micalizzi, Aurora Parodi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
